These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7686526)

  • 1. [Mechanisms of the effect of interferon (IFN) therapy in patients with type B and C chronic hepatitis].
    Karino Y
    Hokkaido Igaku Zasshi; 1993 May; 68(3):297-309. PubMed ID: 7686526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [2'-5' oligoadenylate synthetase activity in patients with acute viral hepatitis and chronic type B hepatitis, and its clinical significance].
    Komiyama T; Akaike M; Satomura K; Okumura H
    Nihon Ika Daigaku Zasshi; 1991 Jun; 58(3):262-72. PubMed ID: 1715348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of 2',5'-oligoadenylate synthetase activity and HCV genotype in IFN therapy for type C chronic hepatitis.
    Karino Y; Hige S; Matsushima T; Miyazaki T; Toyota J
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1354-9. PubMed ID: 7705748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of interferon on intrahepatic human leukocyte antigens and lymphocyte subsets in patients with chronic hepatitis B and C.
    Hayata T; Nakano Y; Yoshizawa K; Sodeyama T; Kiyosawa K
    Hepatology; 1991 Jun; 13(6):1022-8. PubMed ID: 1711000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells obtained from patients with chronic hepatitis B during interferon therapy].
    Sugawara T
    Hokkaido Igaku Zasshi; 1990 Sep; 65(5):439-54. PubMed ID: 2227795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2',5'-Oligoadenylate synthetase activity in the liver and peripheral blood mononuclear cells of chronic hepatitis patients.
    Ogawa Y
    Gastroenterol Jpn; 1988 Jun; 23(3):279-86. PubMed ID: 2456963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of clinical, histological, and immunological responses to interferon therapy in type non-A, non-B, and type B chronic hepatitis.
    Nakano Y; Kiyosawa K; Sodeyama T; Tanaka E
    Am J Gastroenterol; 1990 Jan; 85(1):24-9. PubMed ID: 1688684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of HLA protein display to activation of 2-5A synthetase in HBe antigen or anti-HBe positive chronic HBV infection.
    Ikeda T; Pignatelli M; Lever AM; Thomas HC
    Gut; 1986 Dec; 27(12):1498-501. PubMed ID: 3804026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [2-5 AS activity in serum and peripheral blood mononuclear cells for chronic active hepatitis C and the relationship to clinical outcome of interferon therapy].
    Toda K; Kumagai N; Iwabuchi N; Suzuki T; Saito H; Morizane T; Hibi T; Ishii H; Tsuchimoto K
    Nihon Rinsho Meneki Gakkai Kaishi; 1997 Oct; 20(5):428-36. PubMed ID: 9391306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interferon therapy of chronic hepatitis].
    Iino S
    Nihon Rinsho; 1992 Aug; 50(8):1978-83. PubMed ID: 1279242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum 2'-5'oligoadenylate synthetase as a monitoring marker of anti-viral effect during interferon therapy for chronic type B hepatitis.
    Karino Y; Sugawara T; Saga A; Yoshida J; Matsushima T; Miyazaki T; Toyota J; Okuuchi Y
    Gastroenterol Jpn; 1989 Apr; 24(2):164-9. PubMed ID: 2744332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of the effects of interferon on chronic hepatitis B and the induction of 2',5'-oligoadenylate synthetase.
    Nishiguchi S; Kuroki T; Otani S; Takeda T; Hirota S; Shimizu Y; Nakajima S; Saito S; Shiomi S; Kobayashi K
    Hepatology; 1989 Jul; 10(1):29-33. PubMed ID: 2472340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C.
    Ballardini G; Groff P; Pontisso P; Giostra F; Francesconi R; Lenzi M; Zauli D; Alberti A; Bianchi FB
    J Clin Invest; 1995 May; 95(5):2067-75. PubMed ID: 7738174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of the interferon-induced 2',5'-oligoadenylate synthetase in patients with chronic hepatitis C.
    Pawlotsky JM; Hovanessian A; Roudot-Thoraval F; Lebon P; Robert N; Bouvier M; Babany G; Duval J; Dhumeaux D
    J Interferon Cytokine Res; 1995 Oct; 15(10):857-62. PubMed ID: 8564707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical study of HLA class 1 antigens on the hepatocytes of patients with chronic hepatitis B.
    Manabe K; Yamada G; Nagashima H
    Gastroenterol Jpn; 1986 Aug; 21(4):357-64. PubMed ID: 2429887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic HLA antigen display in chronic hepatitis B virus infection. Relation to hepatic expression of HBV genome/gene products and liver histology.
    Lau JY; Bird GL; Naoumov NV; Williams R
    Dig Dis Sci; 1993 May; 38(5):888-95. PubMed ID: 7683263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 9-cis retinoic acid enhances the antiviral effect of interferon on hepatitis C virus replication through increased expression of type I interferon receptor.
    Hamamoto S; Fukuda R; Ishimura N; Rumi MA; Kazumori H; Uchida Y; Kadowaki Y; Ishihara S; Kinoshita Y
    J Lab Clin Med; 2003 Jan; 141(1):58-66. PubMed ID: 12518169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B.
    Furuta M; Akashi K; Nakamura Y; Matsumoto K; Yamaguchi H; Takamatsu S; Shimizu T
    J Interferon Res; 1987 Feb; 7(1):111-9. PubMed ID: 3585079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in the expression of a beta 2-microglobulin epitope on hepatocytes in chronic type C hepatitis on treatment with interferon.
    García-Buey L; López-Botet M; García-Sánchez A; Balboa MA; Aramburu J; García-Monzón C; Acevedo A; Moreno-Otero R
    Hepatology; 1993 Mar; 17(3):372-82. PubMed ID: 7680330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing the response to interferon therapy in chronic hepatitis C. Studies on viral genotype and induction of 2',5'-oligoadenylate synthetase in the liver and peripheral blood cells.
    Grandér D; Hultcrantz R; Weiland O; Xu B; Sangfelt O; Björklund AC; Befrits R; Björkholm M; Gruber A; Kinnman N; Reichard O; Widell A; Einhorn S
    Scand J Gastroenterol; 1996 Jun; 31(6):604-11. PubMed ID: 8789901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.